Atlas Trials

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Clinical trial NCT05497297 · COMPLETED

Trial details

NCT number
NCT05497297
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2022-08-04
Primary completion
2022-10-23
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.